Pharmaxus SRL
Pharmaxus reported total assets of 25,186 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Jul 2026).
The score of Pharmaxus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +137 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaxus's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
Pharmaxus's financial analysis
- Solvency26.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaxus
Pharmaxus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0694.693.808
- VAT number
- BE0694693808
- Peppol
- Registered · 0208:0694693808 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Apr 2018
- Registered office
- 2240 Zandhoven
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmaxus (SRL) has been based in Zandhoven since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 13,337 € and equity of 6,551 €; its revenue is not published. Its solvency stands at 26.0%, below the median of its sector (44.2%).
Companies similar to Pharmaxus
Companies in the same business, of comparable size and area, outside its group.
- ELI Retail sale of pharmaceutical products Genk · balance sheet 53,448 €
- Pharmacie Marievoet Retail sale of pharmaceutical products Auderghem · balance sheet 60,288 €
- MB Pharmaceutics Retail sale of pharmaceutical products Riemst · balance sheet 57,363 €
- OKINEO System Retail sale of pharmaceutical products Colfontaine · balance sheet 64,459 €
- TAM Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 63,040 €
- Apotheker Laura Spiritus Retail sale of pharmaceutical products Linter · balance sheet 62,639 €
- NZpharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 74,203 €
- L.V. Farma Retail sale of pharmaceutical products Hasselt · balance sheet 83,799 €
Frequently asked questions about Pharmaxus
What is the revenue of Pharmaxus?
Pharmaxus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaxus?
In Belgium, the VAT number is the company number prefixed with BE: BE0694693808 for Pharmaxus, if the company is VAT-registered. Its company number (CBE) is 0694.693.808.
Where is the registered office of Pharmaxus?
According to the CBE register, the registered office of Pharmaxus is in 2240 Zandhoven.
What is the equity of Pharmaxus?
At the close of the 2025 financial year, the equity of Pharmaxus amounts to 6,551 €, a solvency of 26.0% of total assets.
Who manages Pharmaxus?
The register lists 1 active mandates at Pharmaxus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaxus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →